KP Tissue (TSE:KPT) had its target price reduced by equities researchers at Royal Bank of Canada from C$16.00 to C$14.00 in a note issued to investors on Friday. The brokerage currently has an “outperform” rating on the stock. Royal Bank of Canada’s price target points to a potential upside of 15.80% from the stock’s previous close.
Separately, National Bank Financial reduced their price objective on shares of KP Tissue from C$17.00 to C$15.50 and set a “sector perform” rating on the stock in a research report on Thursday, November 9th.
Shares of KP Tissue (TSE:KPT) opened at C$12.09 on Friday. The stock has a market cap of $112.86, a P/E ratio of -67.17 and a beta of 0.63. KP Tissue has a 1 year low of C$11.77 and a 1 year high of C$16.34.
KP Tissue Inc is a Canada-based company, created to acquire, and its business is limited to holding, a limited partnership interest in Kruger Products L.P. (KPLP). KPLP is a tissue products supplier, which produces, distributes, markets and sells bathroom and facial tissue, paper towels and napkins, for both the Consumer and the Away-From-Home (AFH) markets.
Receive News & Ratings for KP Tissue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue and related companies with MarketBeat.com's FREE daily email newsletter.